Cascadia of Boise maintained conflicting physician orders for Resident #87's seizure medications for more than two years without seeking clarification, federal inspectors found during a November complaint investigation.
The 87-year-old woman lives with spastic quadriplegic cerebral palsy, which causes stiff muscles and movement difficulties in all four limbs, her trunk, and face due to early-life brain damage. She also has a seizure disorder and congenital hydrocephalus, a condition where excess cerebrospinal fluid builds up in the brain, increasing pressure and potentially causing brain injury and developmental problems.
Her medical record contained two separate orders for rescue seizure medications with overlapping triggers that left staff guessing which drug to administer during emergencies.
The first order, dated July 13, 2023, prescribed Nayzilam Nasal Solution containing midazolam, a benzodiazepine anticonvulsant. Staff were instructed to give one spray in one nostril "as needed for seizure that lasts for more than 5 minutes or for more than 3 seizures in 24 hours."
Two years later, on July 23, 2025, physicians added a second rescue medication order. Valtoco Nasal Liquid contains diazepam, also a benzodiazepine anticonvulsant. The order directed staff to "give 15 MG in 1 nostril as needed for seizure lasting 5 minutes or 2 seizures in 24 hours."
Both medications target the same type of seizure emergency. Both are administered the same way. But their dosing triggers overlap in dangerous ways.
If Resident #87 experienced a seizure lasting five minutes, staff faced an impossible choice. The Nayzilam order said to give the medication for seizures lasting "more than 5 minutes." The Valtoco order said to give it for seizures "lasting 5 minutes."
The confusion extended to multiple seizure episodes. Nayzilam was ordered for "more than 3 seizures in 24 hours" while Valtoco was prescribed for "2 seizures in 24 hours."
A resident experiencing exactly two seizures in one day, or a single five-minute seizure, could receive either medication, both medications, or neither, depending on how staff interpreted the overlapping instructions.
The Acting Director of Nursing acknowledged the problem during the September 26, 2025 inspection. At 10:02 AM, she told investigators that "Resident #87's Nayzilam and Valtoco directions were not clear which medication should be given when they had a seizure and needed to be clarified to avoid medication error or over medication."
Both drugs belong to the same class of benzodiazepine medications. Giving both during the same seizure episode could result in over-sedation, respiratory depression, or other serious complications, particularly dangerous for someone with Resident #87's complex medical conditions.
The facility had maintained these contradictory orders for more than two years without resolving the ambiguity. The original Nayzilam order from July 2023 remained active when the conflicting Valtoco order was added in July 2025.
Federal regulations require nursing homes to ensure each resident's drug regimen is free from unnecessary medications and that medication administration follows clear, unambiguous orders. Facilities must seek clarification from prescribing physicians when orders create potential for medication errors.
Cascadia of Boise failed to take these steps despite having two years to identify and resolve the conflicting instructions. The facility's medication administration records did not indicate any attempts to contact the prescribing physician for clarification of the overlapping orders.
Resident #87's vulnerability made the medication confusion particularly concerning. Her spastic quadriplegic cerebral palsy affects her entire body, while her seizure disorder requires precise medication management to prevent life-threatening episodes. The hydrocephalus adds another layer of neurological complexity requiring careful monitoring of any medications that could affect brain function.
During seizure emergencies, nursing staff must act quickly to prevent brain damage or death. Unclear medication orders force them to make split-second decisions about powerful drugs without proper guidance, placing residents at risk for both under-treatment and dangerous over-medication.
The inspection found that medication order clarification failures affected few residents overall, but the consequences for Resident #87 could have been severe. Benzodiazepine medications require precise dosing and timing, particularly for residents with multiple neurological conditions.
Staff interviews revealed awareness of the problem months before the federal inspection, yet the facility took no documented action to resolve the conflicting orders or protect Resident #87 from potential over-medication.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Cascadia of Boise from 2025-11-19 including all violations, facility responses, and corrective action plans.